Open Access

Erratum to: Metastatic Merkel cell carcinoma response to nivolumab

  • Frances M. Walocko1,
  • Benjamin Y. Scheier2,
  • Paul W. Harms3, 4,
  • Leslie A. Fecher2 and
  • Christopher D. Lao2Email author
Journal for ImmunoTherapy of Cancer20175:27

https://doi.org/10.1186/s40425-017-0221-x

Received: 6 February 2017

Accepted: 7 February 2017

Published: 6 March 2017

The original article was published in Journal for ImmunoTherapy of Cancer 2016 4:79

Erratum

Following publication of this article [1], it was noticed that the Clinical Trial Number in the last paragraph of the conclusions section was incorrectly listed as NCT02155647. The correct Clinical Trials Number is NCT02488759.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
University of Michigan Medical School
(2)
Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan
(3)
Department of Pathology, University of Michigan
(4)
Department of Dermatology, University of Michigan

Reference

  1. Walocko FM, Scheier BY, Harms PW, Fecher LA, Lao CD. Metastatic Merkel cell carcinoma response to nivolumab. J Immunother Cancer. 2016;4:79. doi:https://doi.org/10.1186/s40425-016-0186-1.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement